Atlas Venture Life Science Advisors, LLC Kymera Therapeutics, Inc. Transaction History
Atlas Venture Life Science Advisors, LLC
- $751 Million
- Q2 2024
A detailed history of Atlas Venture Life Science Advisors, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Atlas Venture Life Science Advisors, LLC holds 5,350,422 shares of KYMR stock, worth $249 Million. This represents 21.28% of its overall portfolio holdings.
Number of Shares
5,350,422
Previous 5,377,362
0.5%
Holding current value
$249 Million
Previous $216 Million
26.12%
% of portfolio
21.28%
Previous 27.05%
Shares
5 transactions
Others Institutions Holding KYMR
# of Institutions
164Shares Held
63.1MCall Options Held
22.6KPut Options Held
14.4K-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$297 Million0.02% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$279 Million2.38% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$240 Million4.71% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.82MShares$224 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA4.31MShares$200 Million0.02% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.54B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...